Authors: LEANDER P HOGLUND P KLOSTER Y BORSETH A

Citation: P. Leander et al., NEW LIPOSOMAL LIVER-SPECIFIC CONTRAST AGENT FOR CT - FIRST HUMAN PHASE-I CLINICAL-TRIAL ASSESSING EFFICACY AND SAFETY, Academic radiology, 5, 1998, pp. 6-8

Authors: ASLANIAN V LEMAIGNEN H BUNOUF P SVALAND MG BORSETH A LUNDBY B

Citation: V. Aslanian et al., EVALUATION OF THE CLINICAL SAFETY OF GADODIAMIDE INJECTION, A NEW NONIONIC MRI CONTRAST-MEDIUM FOR THE CENTRAL-NERVOUS-SYSTEM - A EUROPEAN PERSPECTIVE, Neuroradiology, 38(6), 1996, pp. 537-541

Authors: ASLANIAN V LEMAIGNEN H BUNOUF P SCHIRATTI M LAMBRECHTS M LUNDBY B BORSETH A SVALAND M

Citation: V. Aslanian et al., EVALUATION OF THE CLINICAL SAFETY OF GADO DIAMIDE INJECTION (OMNISCAN(R)), A NEW NONIONIC MR CONTRAST AGENT FOR THE CENTRAL-NERVOUS-SYSTEM, Journal de radiologie, 76(7), 1995, pp. 431-434

Authors: DEMAEREL P MARCHAL G WILMS G VANCALENBERGH F DEGREEF D BORSETH A BAERT AL

Citation: P. Demaerel et al., GADODIAMIDE INJECTION AT 0.1-MMOL KG AND 0.3-MMOL/KG BODY-WEIGHT - A PHASE-III DOUBLE-BLIND, PARALLEL, RANDOMIZED CLINICAL INVESTIGATION OFKNOWN OR SUSPECTED CENTRAL-NERVOUS-SYSTEM LESIONS AT 1.5-T/, Neuroradiology, 36(5), 1994, pp. 355-359